Co-Diagnostics, Inc. Files 8-K on Shareholder Votes
Ticker: CODX · Form: 8-K · Filed: May 29, 2025 · CIK: 1692415
| Field | Detail |
|---|---|
| Company | Co-Diagnostics, Inc. (CODX) |
| Form Type | 8-K |
| Filed Date | May 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: CODX
TL;DR
CODX filed an 8-K on shareholder votes. Check for details on corporate actions.
AI Summary
Co-Diagnostics, Inc. filed an 8-K on May 29, 2025, reporting on matters submitted to a vote of security holders as of May 28, 2025. The filing details the company's corporate structure, including its state of incorporation (Utah) and fiscal year end (December 31).
Why It Matters
This filing informs shareholders about important corporate actions and decisions that require their input, impacting the company's governance and future direction.
Risk Assessment
Risk Level: low — This is a routine corporate filing regarding shareholder votes and does not indicate immediate financial distress or significant operational changes.
Key Players & Entities
- Co-Diagnostics, Inc. (company) — Filer
- May 28, 2025 (date) — Earliest event reported
- May 29, 2025 (date) — Filing date
- Utah (location) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing for Co-Diagnostics, Inc.?
The primary purpose of this 8-K filing is to report on matters submitted to a vote of security holders.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on May 28, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on May 29, 2025.
In which state is Co-Diagnostics, Inc. incorporated?
Co-Diagnostics, Inc. is incorporated in Utah.
What is the fiscal year end for Co-Diagnostics, Inc.?
The fiscal year end for Co-Diagnostics, Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding Co-Diagnostics, Inc. (CODX).